PharmaShots | Incisive News in 3 Shots

Subscribe Now

Adjuvanted

GSK and Medicago Initiate P-III Trial for Adjuvanted COVID-19 Vaccine Candidate

GSK and Medicago Initiate P-III Trial for Adjuvanted COVID-19 Vaccine Candidate

March 17, 2021

Sanofi and GSK Initiate P-II Study of their Adjuvanted Recombinant Protein-Based COVID-19 Vaccine

Sanofi and GSK Initiate P-II Study of their Adjuvanted Recombinant Protein-Based COVID-19 Vaccine

February 22, 2021

Clover and Dynavax Plan to Initiate P-II/III Trial for Adjuvanted COVID-19 Vaccine Candidate

Clover and Dynavax Plan to Initiate P-II/III Trial for Adjuvanted COVID-19 Vaccine Candidate

February 2, 2021

Sanofi and GSK Collaborate to Develop Adjuvanted COVID-19 Vaccine

Sanofi and GSK Collaborate to Develop Adjuvanted COVID-19 Vaccine

April 14, 2020

Seqirus' Audenz Receives the US FDA's Approval as the First Adjuvanted Cell-Based Pandemic Influenza A (H5N1) Vaccine

Seqirus' Audenz Receives the US FDA's Approval as the First Adjuvanted Cell-Based Pandemic Influenza A (H5N1) Vaccine

February 5, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us